Incomplete quality of life data in randomized trials: missing forms

Statistics in Medicine
D CurranD Machin

Abstract

Analysing quality of life (QOL) data may be complicated for several reasons, such as: repeated measures are obtained; data may be collected on ordered categorical responses; the instrument may have multidimensional scales, and complete data may not be available for all patients. In addition, it may be necessary to integrate QOL with length of life. The major undesirable effects of missing data, in QOL research, are the introduction of biases due to inadequate modes of analysis and the loss of efficiency due to reduced sample sizes. Currently, there is no standard method for handling missing data in QOL studies. In fact, there are very few references to methods of handling missing data in this context. The aim of this paper is to provide an overview of methods for analysing incomplete longitudinal QOL data which have either been presented in the QOL literature or in the missing data literature. These methods of analysis include complete case, available case, summary measures, imputation and likelihood-based approaches. We also discuss the issue of bias and the need for sensitivity analyses.

Citations

Dec 31, 2009·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Wendy J PostSaskia le Cessie
Jun 28, 2011·Critical Care Medicine·Raina M MerchantUNKNOWN American Heart Association Get With The Guidelines-Resuscitation Investigators
Dec 1, 2004·Statistics in Medicine·Stephen J Walters, Michael J Campbell
Mar 30, 2005·IEEE Transactions on Pattern Analysis and Machine Intelligence·Chee-Peng LimMei-Ming Kuan
Dec 26, 2006·European Journal of Heart Failure·Eldrin F LewisUNKNOWN CHARM Investigators
Feb 27, 2020·Journal of Evaluation in Clinical Practice·Rosalba RosatoDaniela di Cuonzo
Apr 2, 2002·Statistical Methods in Medical Research·D CurranR J Sylvester
Jun 28, 2005·Breast Cancer Research and Treatment·Andrea A ThorntonJohn P Pierce
Sep 15, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J BrownM D Peake
Jun 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Desmond CurranJames A Bonner
Dec 1, 2001·Journal of Biopharmaceutical Statistics·S J WaltersR Lall
Sep 28, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gary W Donaldson, Carol M Moinpour
Aug 13, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Farzan SiddiquiBenjamin Movsas
Nov 20, 2016·International Journal of Rheumatic Diseases·Yu Heng KwanTruls Østbye
Apr 3, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L FallowfieldJ Cuzick
Jan 16, 2007·Journal of Biopharmaceutical Statistics·L W HusonM Salgo
Jun 24, 2006·World Journal of Surgery·Kerry Avery, Jane M Blazeby
Feb 13, 2010·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Tor MelbergDennis W T Nilsen
Jan 1, 2015·Health and Quality of Life Outcomes·Amélie AnotaCaroline Bascoul-Mollevi
Sep 1, 2014·Current Treatment Options in Oncology·Terri S Armstrong, Mark R Gilbert
Jan 25, 2017·Acta Oncologica·Are KristensenBjørn H Grønberg
Sep 24, 2015·Health and Quality of Life Outcomes·Gillles NuemiCatherine Quantin
Aug 31, 2016·Asia-Pacific Journal of Clinical Oncology·Rebecca L Mercieca-BebberUNKNOWN Australian Ovarian Cancer Study (AOCS) Group
Feb 25, 2014·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Élodie de BockVéronique Sébille
Dec 16, 2010·Expert Review of Pharmacoeconomics & Outcomes Research·Farzan SiddiquiBenjamin Movsas
Apr 26, 2011·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Tolulope T SajobiCharles N Bernstein
Mar 14, 2007·Research in Social & Administrative Pharmacy : RSAP·Christine BonoBruce Vogel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.